SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3042% above fair value
$23.16−0.25 (-1.07%)
Close on Nov 17, 2026Market cap $1.04BP/E –Yield 0.00%
Si-Bone cash
Cash and short-term investments held at the end of each period.
Si-Bone's cash was $141.42M at Jun 30, 2026. For fiscal 2025 it was $139.11M, down 2.3% from the year before. The highest annual figure on record is $196.40M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.11M | -2.3% |
| FY2024 | Dec 31, 2024 | $142.42M | -8.8% |
| FY2023 | Dec 31, 2023 | $156.08M | +84.5% |
| FY2022 | Dec 31, 2022 | $84.58M | -40.2% |
| FY2021 | Dec 31, 2021 | $141.39M | -28.0% |
| FY2020 | Dec 31, 2020 | $196.40M | +111.0% |
| FY2019 | Dec 31, 2019 | $93.10M | -23.8% |
| FY2018 | Dec 31, 2018 | $122.20M | +445.3% |
| FY2017 | Dec 31, 2017 | $22.41M | -19.7% |
| FY2016 | Dec 31, 2016 | $27.90M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $141.42M | +1.6% |
| Q1 FY2026 | Mar 31, 2026 | $140.12M | +1.7% |
| Q4 FY2025 | Dec 31, 2025 | $139.11M | -2.3% |
| Q3 FY2025 | Sep 30, 2025 | $140.66M | -4.2% |
| Q2 FY2025 | Jun 30, 2025 | $139.22M | -5.7% |
| Q1 FY2025 | Mar 31, 2025 | $137.74M | -7.4% |
| Q4 FY2024 | Dec 31, 2024 | $142.42M | -8.8% |
| Q3 FY2024 | Sep 30, 2024 | $146.76M | -3.5% |
| Q2 FY2024 | Jun 30, 2024 | $147.64M | -2.7% |
| Q1 FY2024 | Mar 31, 2024 | $148.74M | +89.2% |
| Q4 FY2023 | Dec 31, 2023 | $156.08M | +84.5% |
| Q3 FY2023 | Sep 30, 2023 | $152.02M | +57.2% |
| Q2 FY2023 | Jun 30, 2023 | $151.67M | +523.7% |
| Q1 FY2023 | Mar 31, 2023 | $78.60M | +187.6% |
| Q4 FY2022 | Dec 31, 2022 | $84.58M | -40.2% |
| Q3 FY2022 | Sep 30, 2022 | $96.68M | -39.9% |
| Q2 FY2022 | Jun 30, 2022 | $24.32M | -86.2% |
| Q1 FY2022 | Mar 31, 2022 | $27.33M | -85.2% |
| Q4 FY2021 | Dec 31, 2021 | $141.39M | -28.0% |
| Q3 FY2021 | Sep 30, 2021 | $160.85M | +21.8% |
| Q2 FY2021 | Jun 30, 2021 | $176.63M | +28.3% |
| Q1 FY2021 | Mar 31, 2021 | $185.05M | +27.7% |
| Q4 FY2020 | Dec 31, 2020 | $196.40M | +111.0% |
| Q3 FY2020 | Sep 30, 2020 | $132.02M | +37.2% |
| Q2 FY2020 | Jun 30, 2020 | $137.67M | +33.3% |
| Q1 FY2020 | Mar 31, 2020 | $144.94M | +1053.9% |
| Q4 FY2019 | Dec 31, 2019 | $93.10M | -23.8% |
| Q3 FY2019 | Sep 30, 2019 | $96.22M | +587.1% |
| Q2 FY2019 | Jun 30, 2019 | $103.28M | +536.2% |
| Q1 FY2019 | Mar 31, 2019 | $12.56M | -29.4% |
| Q4 FY2018 | Dec 31, 2018 | $122.20M | +445.3% |
| Q3 FY2018 | Sep 30, 2018 | $14.00M | -24.3% |
| Q2 FY2018 | Jun 30, 2018 | $16.23M | -41.8% |
| Q1 FY2018 | Mar 31, 2018 | $17.79M | – |
| Q4 FY2017 | Dec 31, 2017 | $22.41M | – |
| Q3 FY2017 | Sep 30, 2017 | $18.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.90M | – |
See a number that looks wrong?